Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-07-25
1998-04-07
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540557, A01N 4362, C07D24310
Patent
active
057365415
ABSTRACT:
The invention provides Form II, a pharmaceutically elegant, stable polymorph of olanzapine useful for treating a condition selected from the group consisting of a psychotic condition, mild anxiety and gastrointestinal conditions.
REFERENCES:
patent: 4115568 (1978-09-01), Chakrabarti et al.
patent: 4115574 (1978-09-01), Chakrabarti et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5457101 (1995-10-01), Greenwood et al.
J. K. Chakrabarti, et al., J. Med. Chem., 23, pp. 878-884, (1980).
Bunnell Charles Arthur
Hendriksen Barry Arnold
Larsen Samuel Dean
Boone David E.
Eli Lilly and Company
Ngo Tamthom T.
Shah Mukund J.
LandOfFree
Olanzapine polymorph crystal form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Olanzapine polymorph crystal form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Olanzapine polymorph crystal form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-13817